<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0003545'>Increased alcohol consumption</z:mp> is a putative <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) risk factor </plain></SENT>
<SENT sid="1" pm="."><plain>However, existing data are less conclusive for women than men </plain></SENT>
<SENT sid="2" pm="."><plain>Also, to date, relatively few studies have reported alcohol-related <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risks based on molecularly defined <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subtypes </plain></SENT>
<SENT sid="3" pm="."><plain>We evaluated associations between alcohol intake and incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, overall and by microsatellite instability [MSI high (MSI-H) or MSI low/microsatellite stable (MSI-L/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>)], CpG island methylator phenotype (CIMP positive or CIMP negative), and BRAF mutation (mutated or <z:mp ids='MP_0002169'>wild-type</z:mp>) status in the prospective, population-based Iowa Women's Health Study (IWHS; n = 41,836) </plain></SENT>
<SENT sid="4" pm="."><plain>Subjects were 55 to 69 years at baseline (1986), and exposure data were obtained by self-report </plain></SENT>
<SENT sid="5" pm="."><plain>Incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> were prospectively identified and archived, paraffin-embedded tissue specimens were collected from 732 representative cases, diagnosed through December 31, 2002 </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate Cox regression models were fit to estimate relative risks (RR) and 95% confidence intervals (CI) </plain></SENT>
<SENT sid="7" pm="."><plain>Among alcohol consumers, the median intake (range) was 3.4 (0.9-292.8) g/d </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with nonconsumers, alcohol intake levels of 3.4 g/d or less (RR = 1.00; 95% CI, 0.86-1.15) and more than 3.4 g/d (RR = 1.06; 95% CI, 0.91-1.24) were not significantly associated with overall <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk </plain></SENT>
<SENT sid="9" pm="."><plain>Analyses based on alcohol intake levels of 30 g/d or less and more than 30 g/d or quartile distributions yielded similar risk estimates </plain></SENT>
<SENT sid="10" pm="."><plain>Null associations were also observed between each alcohol intake level and the MSI-, CIMP- or, BRAF-defined <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> subtypes (P &gt; 0.05 for each comparison) </plain></SENT>
<SENT sid="11" pm="."><plain>These data do not support an adverse effect from alcohol intake on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk, overall or by specific molecularly defined subtypes, among older women </plain></SENT>
</text></document>